Basket (0)
Wishlist (0)
Your personal newsletter
__

Nanomedicine for Inflammatory Diseases

 
Edition number: 1
Publisher: CRC Press
Date of Publication:
 
Normal price:
Publisher's listprice:
GBP 44.99
Estimated price in HUF:
21 730 HUF (20 695 HUF + 5% VAT)
Why estimated?
 
Your price:
17 384 (16 556 HUF + 5% VAT )
discount is: 20% (approx 4 346 HUF off)
Discount is valid until: 30 June 2024
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
 
Availability:
Estimated delivery time: In stock at the publisher, but not at Prospero's office. Delivery time approx. 3-5 weeks.
Not in stock at Prospero.
Can't you provide more accurate information?
 
Add to basket
  Piece(s)

 
Short description:

Uniting the expertise of leading researchers dealing with inflammatory disease and high caliber nanomedicine scientists developing new therapies for treating these diseases, this book bridges the gap between the laboratory bench top and the clinical bedside. A good resource for biomedical researchers, clinicians, and professors of graduate cours

Long description:

Nanomedicine for Inflammatory Diseases is a cutting-edge resource for clinicians and scientists alike, working at the intersection of development and clinical therapeutics. This text is ideal for graduate level courses in nanomedicine, translational medicine, or inflammatory disease. This book is a progressive hallmark in translational medicine as it unites clinicians treating inflammatory disease with scientists developing experimental nanomedicine therapeutics. The commonality is made through a translational nanomedicine expert ? bridging the gap between the laboratory benchtop and the clinical bedside.

Table of Contents:

Part I ? Introduction: Introduction



to Inflammatory Disease,



Nanomedicine, and



Translational Nanomedicine



1 ? FUNDAMENTALS OF IMMUNOLOGY



AND INFLAMMATION





2 ? PRINCIPLES OF NANOMEDICINE





3 ? NANOTOXICITY





4 ? TRANSLATIONAL NANOMEDICINE





Part II ? Introduction: Primary



Inflammatory Disease



5.1 ? BIOLOGY AND CLINICAL TREATMENT



OF INFLAMMATORY BOWEL DISEASE





5.2 ? NANOTHERAPEUTICS FOR



INFLAMMATORY BOWEL DISEASE





5.3 ? BRIDGING THE GAP BETWEEN



THE BENCH AND THE CLINIC:



INFLAMMATORY BOWEL DISEASE





6.1 ? THE BIOLOGY AND CLINICAL



TREATMENT OF MULTIPLE SCLEROSIS





6.2 ? NANOTHERAPEUTICS FOR MULTIPLE



SCLEROSIS





6.3 ? BRIDGING THE GAP BETWEEN THE



BENCH AND THE CLINIC





7.1 ? THE BIOLOGY AND CLINICAL



TREATMENT OF ASTHMA





7.2 ? NANOTHERAPEUTICS FOR ASTHMA





7.3 ? BRIDGING THE GAP BETWEEN THE



BENCH AND THE CLINIC: ASTHMA





Part III ? Introduction:



The Emerging Role



of Inflammation



in Common Diseases



8 ? NEURODEGENERATIVE DISEASE





9 ? CANCER





10 ? DIABETES





11 ? CONCLUDING REMARKS